Anna Schmitt

Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial

Franck Morschhauser, Hervé Tilly, Aristeidis Chaidos et al. · The Lancet Oncology · 2020 · 587 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Management and outcome of primary CNS lymphoma in the modern era

Caroline Houillier, Carole Soussain, Hervé Ghesquières et al. · Neurology · 2020 · 245 citations · Full text

Medicine, Oncology, Chemotherapy +12

IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas

Nathalie Gachard, Marie Parrens, Isabelle Soubeyran et al. · Leukemia · 2012 · 174 citations

Life Sciences, Genetics, Oncology +17

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study

Caroline Houillier, Sylvain Dureau, Luc Taillandier et al. · Journal of Clinical Oncology · 2022 · 101 citations

Medicine, Oncology, Radiation Oncology +14

Molecular and clinical diversity in primary central nervous system lymphoma

Isaias Hernández-Verdín, E. Kirasic, Kirsty Wienand et al. · Annals of Oncology · 2022 · 83 citations · Full text

Medicine, Oncology, Pathology +17